Table S1. The clinicopathological data of the 12 true PSCC patients.

Slides:



Advertisements
Similar presentations
Cervical Cancer.
Advertisements

CRITICAL APPRAISAL ON AN ARTICLE ABOUT PROGNOSIS
Radiologic Imaging Defines the local extent of a tumor Can be used to stage malignant disease Aids in the diagnosis Monitoring tumor changes after treatment.
Multimodality Therapy of Rectal Cancer Robert D. Madoff, MD University of Minnesota.
In the name of God Isfahan medical school Shahnaz Aram MD.
AUDIT OF COMPLIANCE WITH NHSCSP GUIDELINES REQUIRING MDT REVIEW OF ALL CERVICAL CANCER PATIENTS Dr. M Bhattacharjee Dr. A Mutton Dr. S Nagarajan.
Case Presentations Honduras 2011 Pedro T. Ramirez, M.D. Professor Director of Minimally Invasive Research & Education Department of Gynecologic Oncology.
Age-standardized incidence of cervical cancer in selected worldwide countries Zimbabwe, Harare Peru, Trujilo India, Madras Colombia, Cali Argentina India,
SURGICAL APPROACH TO GYNAECOLOGICAL CANCERS
The Dept. OB/GY of the first hospital of Xi’an Jiao Tong university The Dept. OB/GY of the first hospital of Xi’an Jiao Tong university Cervical carcinoma.
IL BCCP Questions.
CARCINOMA OF THE UTERINE CERVIX BY: DR
Carcinoma of the Vulva.
In biochemical recurrence after curative treatment of prostate cancer, Choline PET/CT 1- has a detection rate of 10-20% when PSA: 1-2 ng/ml 2- has a detection.
Cervical Cancer Keith Unger 2/24/06. Clinical History 47 yo F with vaginal bleeding and pelvic pain On exam, large cervical mass with parametrial involvement.
62 years old man Main complaint: Back pain at night but not during the day Loss of appettite Weight loss.
Breast Cancer By: Vincent Russo And Scott Jeffery.
Management of Gynaecological Cancers. Gynaecological Cancers in NSW 1180 new cases in % of all new cancer diagnoses Crude incidence rate 35.3 per.
Cervical Cancer. Cervix Lower part of the uterus Lower part of the uterus Connects the body of the uterus to the vagina (birth canal) Connects the body.
Algorithms for management of Cervical cancer Algorithms for management of cervical cancer are based on existing protocols and guidelines within the ESGO.
CIN & Cervical Cancer Women ’ s Hospital, School of Medicine, Zhejiang university.
Case Study 63: Cancer of the Female Breast
Stage II Stage II - Invasive cancer with tumor extending beyond the cervix and/or the upper two-thirds of the vagina, but not onto the pelvic wall. –Stage.
The Management of Cervical , Vulvar and Vaginal Cancers
Endometrial Carcinoma
Moderators: David Cort, MD Alex Denes, MD Panelists: Stephen Swisher, MD, PhD Edward Lin, MD.
Cancer Cx. Que-1 The most common gynecological malignancy in the world is – a) Vaginal Ca b) Cervical Ca c) Uterine Ca d) Ovarian Ca.
Radiation Therapy in the Management of Cervical Carcinoma Patrick S Swift, MD Medical Director, Radiation Oncology Alta Bates Comprehensive Cancer Center.
Pathology Reports Nicole Draper, MD.
TEMPLATE DESIGN © Endometrial large cell neuroendocrine carcinoma : a case report Reina Sato, Aiko Kawano, Hiroyuki Shigeta.
Cervical Cancer Xin LU OB/GYN Hospital Fudan University.
Anal Cancer - Case 1  62 years old woman with 6 months history of anal pain  Clinically T 3 squamous cell carcinoma growing anteriorly  Which staging.
In the name of God Cervical Cancer Dr.T allameh MD.
IN THE NAME OF GOD MEHRDAD MOHAMMADI MD Endourology and Laparoscopy 1.
Adjuvant High-Dose-Rate Brachytherapy Alone for Stage I/II Endometrial Adenocarcinoma using a 4-Gray versus 6-Gray Fractionation Scheme Marie Lynn Racine,
LCC REC-1 Φ π π π Φ Φ See Primary and Adjuvant Treatment (LCC REC-3) Observe or See Primary Treatment (LCC REC-3) Rectal Cancer.
Malignant & Pre-malignant Diseases of the Endometrium Jose B Moran MD Assistant Professor III Section of Gynecologic Oncology Department of Obstetrics.
Quality Assurance Report TTUHSC Breast Center of Excellence January 1, 2012 – December 31, 2012 Compiled by Uzma Nazim, M.D.
Adjuvant treatment for endometrial cancer Ameri A Associate Professor of Radiation Oncology Shahid Beheshti University of Medical Sciences Dec Pars.
Invasive cervical cancer. Background Most common cancer of women in Africa, most common gynaecologic cancer, most common cancer of black and coloured.
Vivek Nama UHBT. Surgical staging: Tumour grade Myometrial invasion Lymphovascular space involvement Cervical stromal invasion Spread to regional lymphnodes.
Hysterectomy after Chemoradiotherapy for Stage Ib2 and IIb Cervical Cancer Vivek Nama UHBT.
UTERINE CERVICAL CARCINOMA BASIC MRI PRINCIPLES IMAGING FINDINGS S TAGE IV I NVASION OF THE M UCOSA OF B LADDER, R ECTUM OR B OTH ; I NVASION E XTENDING.
Anaplastic thyroid cancer based on ATA guideline for Management of Patients with ATC. Thyroid. 2012;22: R3 이정록.
Treatment for Cervical Cancer
1 Virginia Cancer Registrars Association and Virginia Cancer Registry Annual Meeting October 3, 2007.
DON`T LET UTERINE CERVICAL CARCINOMA DRIVE YOU CRAZY: BASIC MRI PRINCIPLES M. Gamo P. Ramos E. Diez E. Barcina P. Quintana.
Cancer of the Uterine Corpus and Cervix David Toub, M.D. Medical Director Newton Interactive.
Foot pain Dr Shrenik Shah Shrey hospital. Clinical details M/23 year -CA student Pain over instep– mild since 2 years but increased since 5 months No.
Cervical cancer. Incidence and mortality Worldwide, cervical cancer accounted for an estimated 530,000 new cancer cases and for 275,000 deaths In developed.
Management of early stage cervical cancer
Meral Aban MD. Professor OBS&GYN Specialist of GYN ONC
Bladder Cancer R. Zenhäusern.
Liver surgery for metachronous hepatic metastases with uterine body and uterine cervix origin – a single center experience Nicolae Bacalbasa (1), Irina.
Breast Cancer Protocol
The utility of the Bethesda category and its association with BRAF mutation in the prediction of papillary thyroid cancer stage Augustas Beiša1, Mindaugas.
Brain imaging prior to lung cancer resection
Cervical Cancer Tiffany Smith HCP 102.
Concurrent chemotherapy and hyperthermia in patients with recurrent cervical cancer after chemoradiation: outcome and survival S.T. Heijkoop1,2; H.C. van.
Prognosis of younger patients in non-small cell lung cancer
Uterine cancer Uterine mesenchymal neoplasms
Cervical Cancer By Salah Taha Fayed Prof. Gynecologic Oncology
Department of Surgery, Taipei Veterans General Hospital Huang Kuo-Hung
מערכת הרבייה באדם ערכו וכתבו: אורית עמיאל-שרון והעיקר האהבה
معيارهاي ارزشيابي برنامه ثبت سرطان دانشگاهي ارسال به موقع اطلاعات (هر سه ماه)(2) گردآوري از لحاظ پيدا كردن موارد جديد سرطاني از منابع ذيل: - ثبت.
Volume 67, Issue 6, Pages (June 2015)
AGC&AIS Setareh Akhavan M.D Gynecologist Oncologist
Primary cutaneous melanoma 90% Primary non cutaneous melanoma 10% Melanomas originate from melanocytes which are derived from embryological.
Fig. 5. Measurement of extramural depth of tumor invasion in T3 rectal cancer. A. MRI measurements on axial (left) and coronal (right) views are 6.1 and.
Axial contrast-enhanced CT demonstrates a myocutaneous fat flap (white arrow) used for reconstruction following resection of a squamous cell carcinoma.
Presentation transcript:

Table S1. The clinicopathological data of the 12 true PSCC patients. Gross Initial diagnosis on FIGO Final dignosis on Depth of Lymphovascular T N M Recurrence and No. appearance colposcopicl selective biopsy MRI findings stage  Treatment(s) *) surgical specimen invasion (mm) space invasion **)  **) prognosis ***) 1 erosion PSCC, invasion (-) no apparent mass CIS conization + LH PSCC, non-invasive - Tis 21M no recurrence 2 papillary lesion IB1 T1b1 35M no recurrence 3 wart-like PSCC, invasion: ambiguous RH 73M no recurrence 4 polypoid 66M no recurrence 5 PSCC, invasion (+) RH + chemo PSCC 1.5 + 68M no recurrence 6 papillary growing, invasion (-) 1.8 25M no recurrence 7 82M no recurrence 8 exophytic papillary growing, invasion (+) IIA1 3.1 T2a1 54M no recurrence 9 27X15mm mass, invasion (+) 37M no recurrence 10 41mm, mass, invasion (+) IB2 radical trachelectomy 12 T1b2 43M no recurrence 11 39X45mm, invasion (+) 35 7M no recurrence papillary growing, invasion (+) bil paramet (+) IIB chemo + RH + radiation + chemo 27 yT2b y0 79M no recurrence Table S1. The clinicopathological data of the 12 true PSCC patients. *) LH = laparoscopic hysterectomy, RH = radical hysterectomy, chemo = chemotherapy **) "y" indicates a performance of preoperative treatment. ***) M = months